Bristol-Myers Squibb Company (BIT:1BMY)

Italy flag Italy · Delayed Price · Currency is EUR
42.85
+1.32 (3.18%)
Last updated: May 12, 2025
3.52%
Market Cap 88.18B
Revenue (ttm) 44.07B
Net Income (ttm) 5.01B
Shares Out n/a
EPS (ttm) 2.47
PE Ratio 17.59
Forward PE 7.30
Dividend 1.72 (4.02%)
Ex-Dividend Date Apr 3, 2025
Volume 140
Average Volume 155
Open 40.92
Previous Close 41.53
Day's Range 40.84 - 42.85
52-Week Range 36.00 - 60.00
Beta n/a
RSI 34.86
Earnings Date Apr 24, 2025

About BIT:1BMY

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company’s products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthrit... [Read more]

Industry Pharmaceutical Preparations
Founded 1887
Employees 34,100
Stock Exchange Borsa Italiana
Ticker Symbol 1BMY
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.